ICC Holdings Inc is an insurance-specialty business based in the US. ICC shares (ICCH) are listed on the NASDAQ and all prices are listed in US Dollars. ICC employs 94 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Guided investing
Our top pick for
Building a portfolio
Our top pick for
Beginners
| Latest market close | $16.72 |
|---|---|
| 52-week range | $13.51 - $19.05 |
| 50-day moving average | $16.76 |
| 200-day moving average | $16.29 |
| Wall St. target price | N/A |
| PE ratio | 7.8484 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $2.11 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $16.72 from 2022-01-19
| 1 week (2022-01-13) | 0.97% |
|---|---|
| 1 month (2021-12-20) | -0.77% |
| 3 months (2021-10-20) | 1.33% |
| 6 months (2021-07-20) | 4.50% |
| 1 year (2021-01-20) | 18.50% |
|---|---|
| 2 years (2020-01-17) | 23.09% |
| 3 years (2019-01-18) | 17.83% |
| 5 years (2017-01-16) | N/A |
Valuing ICC stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ICC's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ICC's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, ICC shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
ICC's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $7.6 million.
The EBITDA is a measure of a ICC's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $59.3 million |
|---|---|
| Operating margin TTM | 11.69% |
| Gross profit TTM | $3.8 million |
| Return on assets TTM | 2.31% |
| Return on equity TTM | 9.15% |
| Profit margin | 10.9% |
| Book value | $24.03 |
| Market capitalisation | $54.5 million |
TTM: trailing 12 months
We're not expecting ICC to pay a dividend over the next 12 months.
Over the last 12 months, ICC's shares have ranged in value from as little as $13.51 up to $19.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ICC's is 0.3018. This would suggest that ICC's shares are less volatile than average (for this exchange).
ICC Holdings, Inc. , together with its subsidiaries, provides property and casualty insurance products to the food and beverage industry in the United States. The company offers commercial multi-peril, liquor liability, workers' compensation, and umbrella liability insurance products. It markets its products through a network of 178 independent agents in Colorado, Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, and Wisconsin. ICC Holdings, Inc. was founded in 1950 and is headquartered in Rock Island, Illinois. .
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.